Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
BXU7F5
|
|||
| Binder Name |
Moxifloxacin hydrochloride
|
|||
| Synonyms |
Moxifloxacin HCl; Avelox; Avalox; Vigamox; Moxifloxacin (Hydrochloride); Proflox; Izilox; BAY 12-8039; UNII-C53598599T; Bay-12-8039; Moxifloxacine hydrochloride; Moxeza; MFCD00949117; C53598599T; DSSTox_CID_25921; DSSTox_RID_81224; DSSTox_GSID_45921; 186826-86-8 (HCl); 354812-41-2 (free base); Octegra; Actira; Vigamox (TN); Avelox (TN); Moxivig; Vegamox; BAY12-8039 HCl; Moxifloxacin, HCl; NCGC00095130-01; BAY12-8039; Moxifloxacin hydrochloride [USAN:USP]; AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER; CPD000469185; cc-97; C21H25ClFN3O4; SCHEMBL37285; MLS001401368; CHEMBL1200735; DTXSID4045921; ACT02692; BCP03623; Tox21_111439; AL-15469A; CM0156; Moxifloxacin hydrochloride (JAN/USP); AKOS015920132; AKOS016015225; Tox21_111439_1; AC-1275; BCP9000963; CCG-100924; CS-1063; KS-1181; NC00174; NCGC00271749-02; AT-15459; BR-72941; HY-66011; SMR000469185; BCP0726000173; AB0016427; Moxifloxacin hydrochloride, >=98% (HPLC); M2479; S1465; SW197554-3; D00874; S-3681; 826M868; Q27107395; 186826-86-8 151096-09-2(base); Moxifloxacin hydrochloride, VETRANAL(TM), analytical standard; Moxifloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard; Moxifloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C21H25ClFN3O4
|
|||
| Canonical SMILES |
COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl
|
|||
| InChI |
1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1
|
|||
| InChIKey |
IDIIJJHBXUESQI-DFIJPDEKSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:7008
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.